Steve Jobs isn’t saying why he’s taking a medical leave. Slate asks: Is that fair to Apple investors? Investors consider him the driving creative force behind Apple’s most successful products. But Jobs’ hesitancy to reveal details about his own health is problematic, making it difficult for investors to consider whether and how his ailments might influence Apple going forward. Investors aren’t just pricing in bad news about Steve Jobs’ health. They’re pricing in uncertainty about whether Jobs’ condition is so bad that he won’t return. Are Apple shareholders owed more information? Or is Jobs’ desire for privacy both lawful and legitimate?